Toggle navigation
Home
Search
Services
Blog
Contact
About
Production & Safety Testing of Clin. Retrovirus, Adenov
Gilly, John
Bioreliance Corporation, Rockville, MD, United States
Search grants from John Gilly
Search grants from Bioreliance Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Implementation and Implications of Sickle Cell Trait Screening in the NCAA
New York / New Jersey Preparedness and Emergency Response Learning Center
Development of Group II mGluR Radiotracers
Particle Physics in an Era of Data
CNH/EID: The Vector Mosquito Aedes aegypti at the Margins: Sensitivity of a Coupled Natural and Human System to Climate Change
Recently added grants:
Nephrotoxic mechanisms of f low-rank coal (lignite) leachates in drinking water
Multimodal Gating Mechanisms of TRPV1 Ion Channels
Function and Regulation of SLC13A5 in the Liver
Alignment of PrEP use with HIV risk in young women
Feasibility and validation of an integrated newborn screening algorithm with targeted Next Generation Sequencing (tNGS) technology as part of a 2nd-tier test for Pompe and MPS I
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy And Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AO002741-000
Application #
6370247
Study Section
Project Start
2000-09-29
Project End
2005-09-28
Budget Start
2000-09-29
Budget End
2001-09-28
Support Year
Fiscal Year
2000
Total Cost
$1,362,025
Indirect Cost
Institution
Name
Bioreliance Corporation
Department
Type
DUNS #
147227730
City
Rockville
State
MD
Country
United States
Zip Code
20850
Comments
Be the first to comment on this grant